Quick Answer
Regen BioPharma Inc reported Shares Outstanding of 39.37 million shares for fiscal year 2025.
Regen BioPharma Inc Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 39.37M | +648.8% |
| 2024 | 5.26M | +50.0% |
| 2023 | 3.51M | +4.5% |
| 2022 | 3.35M | -99.9% |
| 2021 | 4.35B | +171.1% |
| 2020 | 1.61B | +790.1% |
| 2019 | 180.32M | +0.0% |
| 2018 | 180.32M | +29.1% |
| 2017 | 139.70M | -0.0% |
| 2016 | 139.71M | +21.7% |
| 2015 | 114.75M | +122.3% |
| 2014 | 51.61M | +0.0% |
| 2013 | 51.61M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 108.05M | +401.3% | +174.4% |
| September 30, 2025 | 39.37M | +648.8% | +24.8% |
| June 30, 2025 | 31.55M | +621.6% | +46.4% |
| March 31, 2025 | 21.55M | +423.9% | +0.0% |
| December 31, 2024 | 21.55M | +474.7% | +309.9% |
| September 30, 2024 | 5.26M | +50.0% | +20.2% |
| June 30, 2024 | 4.37M | +29.3% | +6.3% |
| March 31, 2024 | 4.11M | +21.7% | +9.7% |
- Regen BioPharma Inc showed an increase of +648.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Regen BioPharma Inc’s shares outstanding has declined by 23.7% (from 51.61 million shares to 39.37 million shares).
- The most recent figure is from Regen BioPharma Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: